Study Shows Majority of Drug Advertisements are Misleading
According to a study published by the Journal of General Internal Medicine, the majority of pharmaceutical advertisements include misleading information.
About the Pharmaceutical Advertising Study
- Currently the U.S. is one of only two countries in which pharmaceutical companies are allowed to advertise their products.
- The study analyzed 168 prescription and over-the-counter advertisements that were randomly selected form the Vanderbilt Television News Archive.
- The advertisements were all aired at between 2008 and 2010 during the 6:30 news slot on major broadcasting networks ABC, CBS, CNN and NBC.
Findings of the Pharmaceutical Advertising Study
- According to researchers, 57 percent of advertisement observed exaggerated benefits, left out vital information, inserted opinion in place of facts, and made meaningless “life” connections.
- 10 percent of the advertisments were determined to include information that was false.
- 6 out of 10 prescription drug advertisements and 8 out of 10 over the counter drug advertisements included misleading or false claims.
- Only 33 percent of the advertisements were declared “objectively true.”
- While such claims would not be allowed on FDA regulated labels, pharmaceutical advertisements are overseen by the FCC, not the FDA.
Contact an Experienced Product Liability Attorney
Thomas J. Henry are leaders in the area of drug and product liability litigation. Our Defective Drug and Products Division have extensive knowledge and resources in order to represent our clients efficiently and aggressively. The Defective Drug and Products Division represent a multitude of people who are battling against manufacturers of medical devices and/ or defective pharmaceuticals.